About

XpertPatient.com is a premium oncology platform connecting newly diagnosed patients and caregivers with survivor-led guidance—enabling pharmaceutical brands to engage high-intent audiences during the highest-value pre-treatment decision window.

Each year, nearly two million families in the U.S. are impacted by a cancer diagnosis—a moment defined by shock, urgency, and an immediate need for answers. Most patients turn to the internet, where information is often fragmented, overly clinical, or misaligned with what they truly need in that moment.

XpertPatient was built to change that.

At the center of the platform is XpertGuided™, an unprecedented survivor-led learning experience that connects patients with individuals who have faced the same diagnosis, navigated the same decisions, and understand the emotional and clinical realities of the journey. This experience is designed specifically for the most critical phase in cancer care—from diagnosis through treatment decision (Day 1 through Week 5)—when patients are actively evaluating options and forming treatment decisions.

Unlike traditional health content platforms or general oncology publishers, XpertPatient delivers guided, stage-specific education grounded in lived experience, enhanced by AI to simplify complex clinical information and personalize the experience to each patient’s needs.

For oncology brands, XpertPatient represents a fundamentally new approach to patient & caregiver reach & engagement.

Through precision decision-window reach, powered by strategic data partnerships, the platform identifies and engages patients at key inflection points—initial diagnosis and disease progression—delivering a high-intent audience while reducing the inefficiencies common in traditional oncology media.

The result is a premium, trusted environment where:
    •     Patients are highly engaged and actively seeking guidance
    •     Time spent is significantly longer than traditional media environments
    •     Messaging aligns to cancer type, stage, and treatment context
    •     Brands achieve 100% share of voice within relevant experiences
    •     Engagement occurs during the most influential and highest-value promotional window

In a market where oncology represents one of the fastest-growing areas of pharmaceutical investment—and where up to 85% of newly diagnosed patients are actively searching for information—XpertPatient delivers what the industry has been missing: timely, trusted, and effective early-journey engagement.

XpertPatient is more than a content platform. It is a next-generation oncology media and decision intelligence platform, purpose-built to improve patient understanding, support better treatment decisions, and enable brands to engage with greater precision, relevance, and impact.